Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Rationale and design of the Edwards SAPIEN-3 periprosthetic leakage evaluation versus Medtronic CoreValve in transfemoral aortic valve implantation (ELECT) trial : A randomised comparison of balloon-expandable versus self-expanding transcatheter aortic valve prostheses.

Abawi M, Agostoni P, Kooistra NH, Samim M, Nijhoff F, Voskuil M, Nathoe H, Doevendans PA, Chamuleau SA, Urgel K, Hendrikse J, Leiner T, Abrahams AC, van der Worp B, Stella PR.

Neth Heart J. 2016 Dec 9. [Epub ahead of print]

PMID:
27943176
2.

Haemodynamic and functional consequences of the iatrogenic atrial septal defect following Mitraclip therapy.

Hart EA, Zwart K, Teske AJ, Voskuil M, Stella PR, Chamuleau SA, Kraaijeveld AO.

Neth Heart J. 2016 Nov 28. [Epub ahead of print] Review.

PMID:
27896596
3.

Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina? A Review of the Literature.

Benedetto D, Abawi M, Stella PR, Nijhoff F, Lakemeier MD, Kortlandt F, Doevendans PA, Agostoni P.

Front Cardiovasc Med. 2016 Oct 21;3:42.

4.

An unexpected huge coronary aneurysm.

Chan YH, Duckers E, Stella PR.

EuroIntervention. 2016 Oct 20;12(9):1175. doi: 10.4244/EIJV12I9A190. No abstract available.

5.

Effect of New Cerebral Ischemic Lesions on the Delirium Occurrence After Transcatheter Aortic Valve Replacement.

Abawi M, Nijhoff F, Agostoni P, de Vries R, Slooter AJ, Emmelot-Vonk MH, Voskuil M, Leiner T, Doevendans PA, Stella PR.

J Am Coll Cardiol. 2016 Sep 27;68(13):1489-90. doi: 10.1016/j.jacc.2016.06.064. No abstract available.

PMID:
27659470
6.

No benefit of additional treatment with exenatide in patients with an acute myocardial infarction.

Roos ST, Timmers L, Biesbroek PS, Nijveldt R, Kamp O, van Rossum AC, van Hout GP, Stella PR, Doevendans PA, Knaapen P, Velthuis BK, van Royen N, Voskuil M, Nap A, Appelman Y.

Int J Cardiol. 2016 Oct 1;220:809-14. doi: 10.1016/j.ijcard.2016.06.283.

7.

Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience.

Abawi M, Nijhoff F, Stella PR, Voskuil M, Benedetto D, Doevendans PA, Agostoni P.

Neth Heart J. 2016 Sep;24(9):544-51. doi: 10.1007/s12471-016-0862-2.

8.

Ultrasound-accelerated Thrombolysis in a Sub-massive Pulmonary Embolism.

Rodríguez-Olivares R, Kraaijeveld AO, Stella PR.

Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):53. doi: 10.1016/j.rec.2016.04.004. English, Spanish. No abstract available.

PMID:
27198126
9.

TriGuard HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement.

Samim M, van der Worp B, Agostoni P, Hendrikse J, Budde RP, Nijhoff F, Ramjankhan F, Doevendans PA, Stella PR.

Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26566. [Epub ahead of print]

PMID:
27121306
10.

Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial.

Grundeken MJ, Garcia-Garcia HM, Kumsars I, Lesiak M, Kayaert P, Dens J, Stella PR, de Winter RJ, Laak LL, Généreux P, Kaplan AV, Leon MB, Wykrzykowska JJ, Onuma Y, Serruys PW.

Catheter Cardiovasc Interv. 2016 Apr 16. doi: 10.1002/ccd.26527. [Epub ahead of print]

PMID:
27083384
11.

Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT: Depending on Who Is Implanted and How You Implant.

Rodríguez-Olivares R, Nijhoff F, Stella PR.

Rev Esp Cardiol (Engl Ed). 2016 Apr;69(4):455. doi: 10.1016/j.rec.2015.12.010. No abstract available.

PMID:
26944350
12.

Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.

Nijenhuis VJ, Bennaghmouch N, Hassell M, Baan J Jr, van Kuijk JP, Agostoni P, van 't Hof A, Kievit PC, Veenstra L, van der Harst P, van den Heuvel AF, den Heijer P, Kelder JC, Deneer VH, van der Kley F, Onorati F, Collet JP, Maisano F, Latib A, Huber K, Stella PR, Ten Berg JM.

Am Heart J. 2016 Mar;173:77-85. doi: 10.1016/j.ahj.2015.11.008.

PMID:
26920599
13.

Incidence, Predictive Factors, and Effect of Delirium After Transcatheter Aortic Valve Replacement.

Abawi M, Nijhoff F, Agostoni P, Emmelot-Vonk MH, de Vries R, Doevendans PA, Stella PR.

JACC Cardiovasc Interv. 2016 Jan 25;9(2):160-8. doi: 10.1016/j.jcin.2015.09.037.

PMID:
26793958
14.

[Innovative therapies for the treatment of refractory angina: the Reducer, a percutaneous device to narrow the coronary sinus].

Benedetto D, Abawi M, Stella PR, Nijhoff F, Agostoni P.

G Ital Cardiol (Rome). 2015 Nov;16(11):625-9. doi: 10.1714/2066.22432. Italian.

PMID:
26571476
15.

Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.

Nijhoff F, Stella PR, Troost MS, Belkacemi A, Nathoe HM, Voskuil M, Samim M, Doevendans PA, Agostoni P.

Clin Res Cardiol. 2016 May;105(5):401-11. doi: 10.1007/s00392-015-0934-0.

16.

Elevated mean neutrophil volume represents altered neutrophil composition and reflects damage after myocardial infarction.

van Hout GP, van Solinge WW, Gijsberts CM, Teuben MP, Leliefeld PH, Heeres M, Nijhoff F, de Jong S, Bosch L, de Jager SC, Huisman A, Stella PR, Pasterkamp G, Koenderman LJ, Hoefer IE.

Basic Res Cardiol. 2015 Nov;110(6):58. doi: 10.1007/s00395-015-0513-6.

17.

Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.

Zimmermann FM, Ferrara A, Johnson NP, van Nunen LX, Escaned J, Albertsson P, Erbel R, Legrand V, Gwon HC, Remkes WS, Stella PR, van Schaardenburgh P, Bech GJ, De Bruyne B, Pijls NH.

Eur Heart J. 2015 Dec 1;36(45):3182-8. doi: 10.1093/eurheartj/ehv452.

18.

Kounis syndrome with cardiogenic shock during transfemoral transcatheter aortic valve replacement.

Benedetto D, Agostoni P, de Waal E, Stella PR.

Coron Artery Dis. 2015 Dec;26(8):726-7. doi: 10.1097/MCA.0000000000000300. No abstract available.

PMID:
26398150
19.

Outcomes of a dedicated stent in coronary bifurcations with large side branches: A subanalysis of the randomized TRYTON bifurcation study.

Généreux P, Kini A, Lesiak M, Kumsars I, Fontos G, Slagboom T, Ungi I, Metzger DC, Wykrzykowska JJ, Stella PR, Bartorelli AL, Fearon WF, Lefèvre T, Feldman RL, Tarantini G, Bettinger N, Minalu Ayele G, LaSalle L, Francese DP, Onuma Y, Grundeken MJ, Garcia-Garcia HM, Laak LL, Cutlip DE, Kaplan AV, Serruys PW, Leon MB.

Catheter Cardiovasc Interv. 2016 Jun;87(7):1231-41. doi: 10.1002/ccd.26240.

PMID:
26397982
20.

Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.

Nijhoff F, Agostoni P, Belkacemi A, Nathoe HM, Voskuil M, Samim M, Doevendans PA, Stella PR.

Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S34-44. doi: 10.1002/ccd.26060.

PMID:
26119971
Items per page

Supplemental Content

Loading ...
Support Center